Attributable mortality of Stenotrophomonas maltophilia Bacteremia

被引：101
|
作者：
Senol, E
DesJardin, J
Stark, PC
Barefoot, L
Snydman, DR
机构：
[1] Tufts Univ New England Med Ctr, Dept Med, Div Geog Med & Infect Dis, Boston, MA 02111 USA
[2] Tufts Univ New England Med Ctr, Div Clin Care Res, Boston, MA 02111 USA
[3] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2002年 / 34卷 / 12期
关键词：
D O I：
10.1086/340707
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A systematic evaluation of the attributable mortality of Stenotrophomonas maltophilia bacteremia was undertaken in a matched, retrospective, case-control study. We determined the attributable mortality rate (26.7%) and mortality risk ratio (an 8-fold increase) of S. maltophilia bacteremia. The attributable mortality rate for S. maltophilia bacteremia is similar to the attributable mortality rate for other nosocomial bloodstream infections.
引用
收藏
页码：1653 / 1656
页数：4
相关论文
共 50 条
  • [31] A Study in the Clinical Characteristics of Stenotrophomonas Maltophilia Bacteremia in Hematological Patients
    Bao, Haiyan
    Chen, Jia
    Wu, Xiaojin
    Ma, Xiao
    Fu, Chengcheng
    Miao, Miao
    Qiu, Huiying
    Sun, Aining
    Wu Depei
    BLOOD, 2015, 126 (23)
  • [32] Stenotrophomonas maltophilia bacteremia:: epidemiology, clinical characteristics and prognostic factors
    Romero, MH
    Gómez, MJG
    Díaz, JP
    Herreros, JMC
    REVISTA CLINICA ESPANOLA, 2000, 200 (06): : 315 - 317
  • [33] Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients
    Boktour, M
    Hanna, H
    Ansari, S
    Bahna, B
    Hachem, R
    Tarrand, J
    Rolston, K
    Safdar, A
    Raad, I
    CANCER, 2006, 106 (09) : 1967 - 1973
  • [34] A study in the clinical characteristics of Stenotrophomonas maltophilia bacteremia in hematological patients
    Kang, M. L.
    Tan, B. H.
    Koh, L. P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 : S69 - S70
  • [35] Clinical chracteristics and prognostic factors in patients with Stenotrophomonas maltophilia bacteremia
    Nukui, Y.
    Hatakeyama, S.
    Shintani, Y.
    Yotsuyanagi, H.
    Moriya, K.
    Koike, K.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E254 - E255
  • [36] Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009
    Araoka, H.
    Baba, M.
    Yoneyama, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (05) : 605 - 608
  • [37] The Difficulty in Administering Appropriate Antimicrobial Therapy for Stenotrophomonas maltophilia Bacteremia
    Yanai, Mitsuru
    Inagaki, Yoshinori
    Tokunaga, Tomohiko
    INTERNAL MEDICINE, 2017, 56 (20) : 2815 - 2815
  • [38] Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains
    Kim, Eun Jin
    Kim, Yong Chan
    Ahn, Jin Young
    Jeong, Su Jin
    Ku, Nam Su
    Choi, Jun Yong
    Yeom, Joon-Sup
    Song, Young Goo
    BMC INFECTIOUS DISEASES, 2019, 19 (01)
  • [39] Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant
    Hsu, Alice J.
    Simner, Patricia J.
    Bergman, Yehudit
    Mathers, Amy J.
    Tamma, Pranita D.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [40] Reply to "The Difficulty in Administering Appropriate Antimicrobial Therapy for Stenotrophomonas maltophilia Bacteremia"
    Ebara, Hirotaka
    Hagiya, Hideharu
    Haruki, Yuto
    Kondo, Eisei
    Otsuka, Fumio
    INTERNAL MEDICINE, 2017, 56 (20) : 2817 - 2817
12345